Cargando…
Toxoplasmosis: Current and Emerging Parasite Druggable Targets
Toxoplasmosis is a prevalent disease affecting a wide range of hosts including approximately one-third of the human population. It is caused by the sporozoan parasite Toxoplasma gondii (T. gondii), which instigates a range of symptoms, manifesting as acute and chronic forms and varying from ocular t...
Autores principales: | Hajj, Rana El, Tawk, Lina, Itani, Shaymaa, Hamie, Maguy, Ezzeddine, Jana, El Sabban, Marwan, El Hajj, Hiba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707595/ https://www.ncbi.nlm.nih.gov/pubmed/34946133 http://dx.doi.org/10.3390/microorganisms9122531 |
Ejemplares similares
-
Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases
por: Daher, Darine, et al.
Publicado: (2021) -
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling
por: Hamie, Maguy, et al.
Publicado: (2021) -
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML
por: Skayneh, Hala, et al.
Publicado: (2022) -
Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
por: Moodad, Sara, et al.
Publicado: (2020) -
Toxoplasma Shelph, a Phosphatase Located in the Parasite Endoplasmic Reticulum, Is Required for Parasite Virulence
por: Najm, Rania, et al.
Publicado: (2022)